Group L P Column's Net Worth
Group L P Column's net worth is estimated to be at least $34,882,196.86 as of 11/23/2024. CoreStreet's estimation of Group L P Column's net worth is based on their sale of stock and current holding of stock.
Group L P Column is Director at NGM Biopharmaceuticals Inc. They have executed at least 52 trades of stock as per SEC Form 4 filings. Their most recent trade was for 7,542 units of NGM stock on 01/30/2023. Their biggest sale was on 10/21/2019 when they sold 30,926 units of NGM Biopharmaceuticals Inc stock for $2,403,568.72. They typically trade 13 times per year.
Total value of insider buys:
- $32,450,428.14
Total value of insider sells:
- $2,431,768.72
Most recent insider trade:
- Jan. 30, 2023
Group L P Column's Insider Trading History
NGM Biopharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|
Jan. 30, 2023 | Director | 7,542 | $5.00 | Buy | $37,710.00 |
Jan. 23, 2023 | Director | 9,900 | $5.00 | Buy | $49,500.00 |
Jan. 19, 2023 | Director | 37,639 | $5.00 | Buy | $188,195.00 |
Jan. 12, 2023 | Director | 5,378 | $4.95 | Buy | $26,621.10 |
Jan. 10, 2023 | Director | 100,070 | $4.84 | Buy | $484,338.80 |
Dec. 12, 2022 | Director | 300 | $4.98 | Buy | $1,494.00 |
Nov. 21, 2022 | Director | 35,997 | $5.00 | Buy | $179,985.00 |
Nov. 3, 2022 | Director | 104,090 | $4.99 | Buy | $519,409.10 |
Oct. 25, 2022 | Director | 51,046 | $4.75 | Buy | $242,468.50 |
June 2, 2022 | Director | 34,200 | $13.03 | Buy | $445,626.00 |
May 31, 2022 | Director | 61,806 | $13.47 | Buy | $832,526.82 |
May 26, 2022 | Director | 20,201 | $13.49 | Buy | $272,511.49 |
May 24, 2022 | Director | 17,828 | $13.37 | Buy | $238,360.36 |
May 19, 2022 | Director | 20,666 | $13.25 | Buy | $273,824.50 |
May 17, 2022 | Director | 89,049 | $13.42 | Buy | $1,195,037.58 |
May 11, 2022 | Director | 83,175 | $11.25 | Buy | $935,718.75 |
May 9, 2022 | Director | 83,175 | $10.79 | Buy | $897,458.25 |
Sept. 1, 2020 | Director | 36,494 | $17.64 | Buy | $643,754.16 |
Aug. 27, 2020 | Director | 36,359 | $17.79 | Buy | $646,826.61 |
Aug. 24, 2020 | Director | 11,024 | $17.96 | Buy | $197,991.04 |
Aug. 21, 2020 | Director | 7,321 | $17.97 | Buy | $131,558.37 |
Aug. 17, 2020 | Director | 6,425 | $17.89 | Buy | $114,943.25 |
Aug. 13, 2020 | Director | 19,895 | $17.89 | Buy | $355,921.55 |
July 30, 2020 | Director | 732 | $17.99 | Buy | $13,168.68 |
July 27, 2020 | Director | 3,834 | $17.99 | Buy | $68,973.66 |
July 24, 2020 | Director | 68,749 | $17.93 | Buy | $1,232,669.57 |
July 22, 2020 | Director | 193 | $18.00 | Buy | $3,474.00 |
April 7, 2020 | Major Shareholder | 138,315 | $14.19 | Buy | $1,962,689.85 |
April 2, 2020 | Major Shareholder | 250,984 | $12.78 | Buy | $3,207,575.52 |
March 25, 2020 | Major Shareholder | 301,180 | $13.33 | Buy | $4,014,729.40 |
March 20, 2020 | Major Shareholder | 143,082 | $11.77 | Buy | $1,684,075.14 |
March 4, 2020 | Major Shareholder | 9,986 | $17.96 | Buy | $179,348.56 |
March 2, 2020 | Major Shareholder | 14,124 | $17.90 | Buy | $252,819.60 |
Feb. 28, 2020 | Major Shareholder | 75,447 | $18.04 | Buy | $1,361,063.88 |
Feb. 26, 2020 | Major Shareholder | 3,751 | $18.00 | Buy | $67,518.00 |
Feb. 6, 2020 | Major Shareholder | 44,900 | $15.47 | Buy | $694,603.00 |
Oct. 21, 2019 | Major Shareholder | 30,926 | $77.72 | Sell | $2,403,568.72 |
Oct. 16, 2019 | Major Shareholder | 103,000 | $10.87 | Buy | $1,119,610.00 |
Oct. 14, 2019 | Major Shareholder | 20,000 | $1.41 | Sell | $28,200.00 |
Oct. 11, 2019 | Major Shareholder | 53,172 | $10.38 | Buy | $551,925.36 |
Aug. 9, 2019 | Major Shareholder | 224,664 | $14.00 | Buy | $3,145,296.00 |
Aug. 2, 2019 | Major Shareholder | 4,382 | $13.98 | Buy | $61,260.36 |
July 23, 2019 | Major Shareholder | 67,742 | $13.49 | Buy | $913,839.58 |
July 16, 2019 | Major Shareholder | 20,088 | $13.72 | Buy | $275,607.36 |
July 12, 2019 | Major Shareholder | 31,884 | $13.88 | Buy | $442,549.92 |
June 24, 2019 | Major Shareholder | 12,240 | $13.78 | Buy | $168,667.20 |
June 21, 2019 | Major Shareholder | 34,377 | $13.90 | Buy | $477,840.30 |
June 11, 2019 | Major Shareholder | 23,500 | $13.74 | Buy | $322,890.00 |
June 6, 2019 | Major Shareholder | 25,200 | $13.40 | Buy | $337,680.00 |
May 20, 2019 | Major Shareholder | 50,000 | $13.50 | Buy | $675,000.00 |
May 10, 2019 | Major Shareholder | 17,923 | $13.85 | Buy | $248,233.55 |
TherapeuticsMD Inc | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|
Oct. 23, 2019 | Major Shareholder | 4,387 | $12.66 | Buy | $55,539.42 |